New allergy shot aims to tame mugwort season in just four weeks
Disease control
Recruiting now
This Phase 2 trial tests PollenVax, a new immunotherapy for people with moderate-to-severe allergic rhinitis caused by mugwort pollen. The treatment is given as four weekly shots before the pollen season. Researchers will compare symptom scores and medication use between the Poll…
Phase: PHASE2 • Sponsor: Kazakh National Agrarian University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC